Basil S Lewis

13PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesSocial determinants of healthCardiology (incl. cardiovascular diseases)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 21, 2025
2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention.

Peter Jüni, Sotiris Antoniou, Elena Arbelo

|Mar 12, 2024
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept.

Massimo Imazio, Allan L Klein, Antonio Brucato

|Jul 18, 2022
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events.

Juan Tamargo, Juan Carlos Kaski, Takeshi Kimura

|Jul 19, 2021
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy.

Victor Aboyans, Rupert Bauersachs, Lucia Mazzolai

|Jun 03, 2021
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.

Ewa A Jankowska, Bridget-Anne Kirwan, Mikhail Kosiborod

|May 08, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.

Jackie Bosch, Eva M Lonn, Hyejung Jung

Pageof 3

Frequent Collaborators

3 joint publications

Juan Tamargo

3 joint publications

Stefan Agewall

2 joint publications

Heinz Drexel

2 joint publications

Juan Carlos Kaski